Risk Factors for Treatment Failure with Oral Antivirals in HCV

Abstract

Introduction: Chronic hepatitis C virus (HCV) infection is one of the major cause of cirrhosis of liver and leads to significant morbidity and mortality. In past, HCV therapy was limited to subcutaneous peg interferon plus oral ribavirin, a regimen that was generally poorly tolerated and provided low efficacy, with cure rates below 40% for HCV genotypes 1 and 4, and below 75% for HCV genotypes 2 or 3. The availability of oral direct-acting antiviral (DAA) as treatment for chronic hepatitis C has revolutionized the field. Although current HCV therapies rarely fail to achieve viral eradication, a subset of patients experience treatment failure. Aim: To study the risk factors associated with treatment failure with oral antiviral drugs in patients of Chronic hepatitis C. Materials & Methods: It was a retrorospective study done at Medical Gastroenterology Department, PGIMS, Rohtak in which six years data i.e.from 01.01.2015 to 31.12.2020, pertainining to Eighty Six (86) chronic hepatitis C patients who had treatment failure i.e. SVR failure on oral antiviral drugs was analyzed. Observations: Out of the total 86 patients, there was clear cut male predominance i.e. 54 (62.79 %) with rural background (villages) i.e.73 (84.88%). The age distribution in these 86 patients varied between 10-80 yrs of age and characterstically peak was seen in 31-40 yrs age group i.e.25 patients (29.06 %). The majority of patients had high baseline HCV viral load (> 4 lakhs I.U. /ml) i.e. 52 patients (60.46%). Out of total 86 patients, , 50 patients (58.13%) were cirrhotic, 34 patients (39.53 %) were smokers, 33 patients (38.37%) were alcoholic, 26 patients (30.23 %) had past history of surgical intervention, 9 patients (10.46 %) were diabetic, 9 patients (10.46 %) had got tattoo, 8 patients (9.30%) had history of previous blood transfusion and 13 patients (15.11%) gave history of use of alternative medications. Results: The direct risk factors associated with development of failed SVR in HCV patients are high baseline HCV RNA viral load, cirrhosis, rural background and indirect risk factors are smoking, alcohol and Diabetes Mellitus but large scale studies in future are required to confirm the same.

Authors and Affiliations

Parveen Malhotra, Vani Malhotra, Yogesh Sanwariya, Dixit , Sahil Girdhar, Shailesh Rathee, Shinepreet Kaur, Sanjeet

Keywords

Related Articles

Validityand Reliability of Champion’s Health Belief Model Scale to Measure Beliefs in Breast Self-Examination Practices in Vietnamese Women

Objective:The purpose of this study was to translate, adjust and evaluate the validity and reliability of the Champion's Health Belief Model scale, so as to measure the beliefs of self-examination practices of Vietnamese...

Aducanumab Opinion

Aducanumab (brand name Aduhelm) is the first FDA-approved, pharmacologic treatment for Alzheimer’s disease (AD)but many uncertainties remain regarding both efficacy and safety. Of paramount concern areassociated...

Erisipelas and its Management in a Tertiary Care Hospital

Erysipelas is an acute dermo-hypodermic (non-necrotizing) infection of bacterial origin, mainly group A beta-hemolytic streptococcus. The lower limbs are affected in more than 80% of cases and the risk factors identified...

Health Implications of Bt Cotton Seeds in Animals and Man

Cotton (Gossypium spp.) is an arborous plant from the Malvaceae family. Cottonseed meal is a by-product of cotton that is used for animal feeding because it is rich in oil and proteins. However, gossypol toxicity limits...

Features and Course of Epilepsy in the Mountain Desert Regions of The Surkhandara Region

This article discusses the features of epilepsy in the mountainous desert areas of Surkhandarya region and how it occurs. Epilepsy is a chronic polyetiological neuropsychiatric disorder that often begins in childhood and...

Download PDF file
  • EP ID EP714075
  • DOI 10.47191/ijmscrs/v2-i5-04
  • Views 49
  • Downloads 0

How To Cite

Parveen Malhotra, Vani Malhotra, Yogesh Sanwariya, Dixit, Sahil Girdhar, Shailesh Rathee, Shinepreet Kaur, Sanjeet (2022). Risk Factors for Treatment Failure with Oral Antivirals in HCV. International Journal Of Medical Science And Clinical Research Studies, 2(05), -. https://europub.co.uk/articles/-A-714075